MENU
CSTL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Castle Biosciences (CSTL) Earnings Date & Reports

Castle Biosciences Inc is a molecular diagnostics company... Show more

A.I. Advisor
published Earnings

CSTL is expected to report earnings to fall 548.00% to -67 cents per share on November 10

Castle Biosciences CSTL Stock Earnings Reports
Q3'25
Est.
$-0.67
Q2'25
Beat
by $0.66
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.31
Q3'24
Beat
by $0.08
The last earnings report on August 04 showed earnings per share of 15 cents, beating the estimate of -50 cents. With 560.77K shares outstanding, the current market capitalization sits at 561.60M.
View a ticker or compare two or three
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CSTL showed earnings on August 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
505 South Friendswood Drive
Phone
+1 866 788-9007
Employees
610
Web
https://www.castlebiosciences.com